The electroanatomical remodelling of the left atrium is related to CHADS 2/CHA 2DS 2VASc score and events of stroke in patients with atrial fibrillation

Europace

Volumn 13, Issue 11, 2011, Pages 1541-1549

  Park, Jae Hyung ^a   Joung, Boyoung ^a   Son, Nak Hoon ^b   Shim, Jae Min ^a   Lee, Moon Hyung ^a   Hwang, Chun ^c   Pak, Hui Nam ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Atrial fibrillation; CHADS 2 score; Left atrium; Stroke; Voltage

Indexed keywords

ADULT; ARTICLE; CATHETER ABLATION; CHA2DS2VASC SCORE; CHADS2 SCORE; CONTROLLED STUDY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE POTENTIAL; HEART VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STROKE;

ADULT; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; HEART ATRIA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ORGAN SIZE; RISK FACTORS; STROKE; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 80054948846     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur135     Document Type: Article

References (33)

1. Page RL. Clinical practice. Newly diagnosed atrial fibrillation. N Engl J Med 2004; 351:2408-16.
2. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the longterm risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-64. (Pubitemid 35223606)
3. Go AS, Hylek EM, Chang Y, Phillips KA, Henault LE, Capra AM et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice? JAMA 2003;290:2685-92. (Pubitemid 37475596)
4. Rietbrock S, Heeley E, Plumb J, van Staa T. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age 75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J 2008;156:57-64. (Pubitemid 351877101)
5. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the management of patients with atrial fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354. (Pubitemid 44252297)
6. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-46. (Pubitemid 34327903)
7. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96:1180-4. (Pubitemid 27344221)
8. Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L et al. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol 2001;33:2083-94. (Pubitemid 34073052)
9. Boldt A, Wetzel U, Lauschke J, Weigl J, Gummert J, Hindricks G et al. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 2004;90:400-5. (Pubitemid 38406914)
10. Park JH, Pak HN, Kim SK, Jang JK, Choi JI, Lim HE et al. Electrophysiologic characteristics of complex fractionated atrial electrograms in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2009;20:266-72.
11. Park JH, Pak HN, Choi EJ, Jang JK, Kim SK, Choi DH et al. The relationship between endocardial voltage and regional volume in electroanatomical remodeled left atria in patients with atrial fibrillation: Comparison of three-dimensional computed tomographic images and voltage mapping. J Cardiovasc Electrophysiol 2009;20:1349-56.
12. Park JH, Park SW, Kim JY, Kim SK, Jeoung B, Lee MH et al. Characteristics of complex fractionated atrial electrogram in the electroanatomically remodeled left atrium of patients with atrial fibrillation. Circ J 2010;74:1557-63.
13. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31: 2369-429.
14. Douglas YL, Jongbloed MR, Gittenberger-de Groot AC, Evers D, Dion RA, Voigt P et al. Histology of vascular myocardial wall of left atrial body after pulmonary venous incorporation. Am J Cardiol 2006;97:662-70. (Pubitemid 43255036)
15. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-8.
16. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70. (Pubitemid 32537350)
17. Fatkin D, Kuchar DL, Thorburn CW, Feneley MP. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for 'atrial stunning' as a mechanism of thromboembolic complications. J Am Coll Cardiol 1994;23:307-16. (Pubitemid 24049357)
18. Missault L, Jordaens L, Gheeraert P, Adang L, Clement D. Embolic stroke after unanticoagulated cardioversion despite prior exclusion of atrial thrombi by transoesophageal echocardiography. Eur Heart J 1994;15:1279-80. (Pubitemid 124005619)
19. Dunn MI, Marcum JL. Atrial mechanical performance following internal and external cardioversion of atrial fibrillation: Its relationship to peripheral embolization and acute cerebrovascular accident. Chest 2002;121:1-3. (Pubitemid 34114216)
20. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002;54:361-79. (Pubitemid 34327915)
21. Nakai T, Chandy J, Nakai K, Bellows WH, Flachsbart K, Lee RJ et al. Histologic assessment of right atrial appendage myocardium in patients with atrial fibrillation after coronary artery bypass graft surgery. Cardiology 2007;108:90-6. (Pubitemid 47295567)
22. Goette A, Bukowska A, Lendeckel U, Erxleben M, Hammwohner M, Strugala D et al. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression. Circulation 2008;117:732-42. (Pubitemid 351640674)
23. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-7. (Pubitemid 39552671)
24. Spach MS, Boineau JP. Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: A major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol 1997;20(Part 2):397-413.
25. Spach MS, Josephson ME. Initiating reentry: The role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol 1994;5:182-209. (Pubitemid 24061992)
26. Verma A, Wazni OM, Marrouche NF, Martin DO, Kilicaslan F, Minor S et al. Preexistent left atrial scarring in patients undergoing pulmonary vein antrum isolation: An independent predictor of procedural failure. J Am Coll Cardiol 2005; 45:285-92. (Pubitemid 40094739)
27. Li X, Ma C, Dong J, Liu X, Long D, Tian Y, Yu R. The fibrosis and atrial fibrillation: Is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation. Med Hypotheses. 2008;70:317-9. (Pubitemid 350297612)
28. Kuppahally SS, Akoum N, Burgon NS, Badger TJ, Kholmovski EG, Vijayakumar S et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: Relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging 2010;3:231-9.
29. Volgman AS, Soble JS, Neumann A, Mukhtar KN, Iftikhar F, Vallesteros A et al. Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: Atrial dimension versus volume. Am J Card Imaging 1996;10:261-5. (Pubitemid 27084767)
30. Tsao HM, Wu MH, Huang BH, Lee SH, Lee KT, Tai CT et al. Morphologic remodeling of pulmonary veins and left atrium after catheter ablation of atrial fibrillation: Insight from long-term follow-up of three-dimensional magnetic resonance imaging. J Cardiovasc Electrophysiol 2005;16:7-12.
31. Connolly SJ, EzekowitzMD, Yusuf S, EikelboomJ,Oldgren J, ParekhAet al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
32. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78.
33. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet 2009;374:534-42.